Is there finally light at the end of the tunnel for Royal Bank of Scotland Group plc?

Royal Bank of Scotland Group plc (LON: RBS) is returning to health.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Royal Bank of Scotland (LSE: RBS) is the one FTSE 100 company everyone loves to hate, and it’s easy to understand why. The bank had to be bailed out by the taxpayer during the financial crisis after years of poor management and misguided acquisitions. And since the crisis, it has lurched from one problem to another with no end in sight to its troubles.

Still struggling

Nearly 10 years on from one of the largest financial crises the world has ever seen and RBS is still struggling to clean up its balance sheet. And as well as the toxic assets it is trying to shift, management is also having to fight off a lawsuit from shareholders who claim they were wrongly mis-sold the bank’s 2008 rights issue and regulators who continue to demand billions of dollars of fines from it. 

Even in a perfect business environment achieving a favourable resolution to these matters for all involved would be difficult. It doesn’t help that RBS is trying to turn itself around in one of the most hostile environments for banks ever seen.

Still, amid the carnage of the RBS balance sheet and legacy issues, there are some gems to be found. It is these gems that will ultimately save the firm and its reputation from collapse, and as long as they continue to achieve returns from RBS, its future is not as bleak as many make it out to be.

A changed beast

Over the past decade, RBS has changed significantly from a global investment bank to a simpler business focused on personal and business banking. Barring the skeletons in the closet, its investment bank is no longer a problem area for the firm.

Its most profitable business is now its Personal & Business Banking, Commercial & Private Banking and NatWest Markets franchises, which produced a 4% increase in adjusted operating profits to £4.3bn for 2016. For these businesses, adjusted return on equity was 11.1% and fourth quarter adjusted operating profit came in at £848m, up 61% from the year-ago period. Overall, the total loss for 2016 came in at just under £7bn. Of this total, a £2.1bn charge was related to restructuring, and there was a further cost of £5.9bn related to litigation and conduct costs. 

Restructuring charges will come to an end at some point. The bank is committed to achieving its sub 50% cost-to-income ratio and 12% return on tangible equity targets by 2020, so we can assume this is a possible end point for restructuring. At the same time, it can be argued RBS’s legacy litigation costs have reached their peak as it awaits its fine for mis-selling toxic mortgage securities from the US authorities, which could be the largest fine paid by the business to date.

Still, when this penalty is paid, and the restructuring charges start to fall away, RBS’s true colours should start to show through. Investors who want to profit from this will have to be patient, but it’s clear there’s a good business hiding under all of RBS’s troubles.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Investing Articles

Surprise! This monopoly stock has taken over my Stocks and Shares ISA (again)

Our writer has a (nice) dilemma in his Stocks and Shares ISA portfolio after one incredible growth stock rocketed higher…

Read more »

Investing Articles

10.5% yield – but could the abrdn share price get even cheaper?

Christopher Ruane sees some things to like about the current abrdn share price. But will that be enough to overcome…

Read more »

Investing Articles

£9,000 to invest? These 3 high-yield shares could deliver a £657 annual passive income

The high yields on these dividend shares sail sit well above the FTSE 100 average of 3.6%. Here's why I…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

I’ve got £2k and I’m on the hunt for cheap shares to buy in December

Harvey Jones finally has some cash in his trading account and is hunting for cheap shares to buy next month.…

Read more »

Investing Articles

Down 25% with a 4.32% yield and P/E of 8.6! Is this my best second income stock or worst?

Harvey Jones bought GSK shares hoping to bag a solid second income stream while nailing down steady share price growth…

Read more »

Investing Articles

Here’s how the Legal & General dividend yield could ultimately hit 15%!

The Legal & General dividend yield is already among the best of any FTSE 100 share. Christopher Ruane explores some…

Read more »

Investing Articles

Is December a good time for me to buy UK shares?

This writer is weighing up which shares to buy for his portfolio next month, and one household name from the…

Read more »

Investing Articles

Is it time to dump my Lloyds shares and never look back?

Harvey Jones was chuffed with his Lloyds shares but recent events have made him rethink his entire decision to go…

Read more »